doubletree by hilton center city philadelphia, pa medical...

REGISTER AT WWW.CBINET.COM/MEDICALAFFAIRS • 800-817-8601

UBM LIFE SCIENCES PUBLICATIONS

R E G I S T E R BY D E C E M B E R 2 3 , 2 0 1 6 A N D S AV E $ 3 0 0 !

A division ofUBM Americas

Medical AffairsAdvancement ForumMSL Best Practices • KOL Engagement Compliant Medical Communications

January 30-31, 2017 | DoubleTree by Hilton Center City | Philadelphia, PA

Maximize Your Medical Science Liaison Capabilities with These Must-Attend Sessions:

Optimize Your MSL Utilization with Tailored Training and Education Panel Discussion

Establishing New KOL Relationships — Lessons LearnedTiama Chaar, Ph.D.,

Oncology MSL,

Sanofi Genzyme

Unparalleled Industry Insights from An Elite Speaking Faculty: • Shontelle Dodson, Vice President, Medical

Excellence/Medical Affairs Global, Astellas

• Kevin Appareti, Senior Director, Global Medical Science Liaison, Philips Healthcare

• Robert Matheis, Executive Director, Head of Global Scientific Communications, Celgene

• Rachel Leder Couchenour, PharmD, MBA, Senior Director, Medical Affairs, Mateon Therapeutics

• Josh Yoder, Medical Science Liaison, Sanofi Pasteur

• Timothy Grimes, Former, Health Care Compliance Officer, North American Pharmaceuticals, Johnson & Johnson

• Angelique Lee-Rowley, US General Counsel & Compliance Officer, Greenwich Biosciences, Inc.

• And more!

DISTINGUISHED CONFERENCE CHAIR Scott McConnell, PharmD, Senior Director, Medical Affairs, Alkermes

Media Partners:

http://www.cbinet.com/medicalaffairs

Medical Affairs

Advancement Forum

Leading Stra

tegies

to Advance Medica

l Scie

nce, En

gage Compliantly

with KOLs

and Ensure

Success

of Medica

l Affairs Tea

ms

January 20-21, 2

016 | Sonesta

Hotel Phila

delphia | Phila

delphia, PA


A Great Place to Meet Your Market!Take advantage of the best opportunity to meet potential clients face-to-face. Build relationships while demonstrating

thought leadership and sharing expertise. For more information on how to position your company as a sponsor or exhibitor, contact Karen Hanover at 339-298-2184 or email [email protected].

Who Should Attend

You will benefit from attending this event if you are a president, VP, or senior level director from the pharmaceutical or biotech industries with responsibilities or involvement in the following areas:

This conference will also benefit consultants and medical education providers that provide services to medical device and pharmaceutical medical affairs teams.

Medical Affairs

Medical Science Liaison

Medical/Scientific

Information

Medical Education Compliance Scientific Affairs

• Hear about the current and emergent trends impacting medical affairs roles

• Address the challenges that arise between medical affairs and commercial functions communications and develop strategies to overcome them

• Dive into the various metrics that demonstrate the value of medical affairs

• Develop standard processes that assist in leading to compliant and effective scientific exchange

• Gain insight into the key communication and networking skills for both MSLs and leadership

• Enhance your MSL training and capabilities for global functions

• Develop a clear set of objectives for engaging with thought leaders

Top 7 Reasons to Attend CBI’s Medical Affairs Advancement Forum

Conference Sponsors Include:

Benefit from enhanced networking with shared breaks and cocktail receptions with attendees from CBI’s Contact Centers– Co-located with Medical Affairs Advancement Forum for unparalleled networking and an exclusive meeting of the minds!

w w w.cbinet .com/contac tcenters

16 T H An n u a l B i o Ph a r m ac e u t i c a l s Co nt ac t Ce nte r s


mailto:[email protected]

http://www.cbinet.com/contactcenters

7:30 Conference Registration and Continental Breakfast

8:30 Chairman’s Opening Remarks Scott McConnell, PharmD, Senior Director, Medical Affairs, Alkermes

8:45 Medical Affairs Evolution in a Value Based World — Moving from an Opinion to an Evidence Based Integrated FunctionAs the industry shifts to value-based healthcare, there is an impending need within organizations to better understand the patient experience, access and influence a broad array of external health care stakeholders, and adopt an evidentiary liaison between the external medical community and the internal research organization focused on medical value & product differentiation. In that regards, medical affairs with its unique set of characteristics is appropriately positioned to move from a physician & opinion based function to an integrated business unit that works closely with a range of stakeholders in an evidence based fashion, strategically brings patient centricity into the medical ecosystem and uncover broad set of insights that can drive clinical, social, and economic value throughout the product lifecycle. During this address, hear about the current and emergent trends impacting medical affairs roles and how evolution looks like in terms of focus and delivery across the industry• Moving beyond physician engagement to — Staying relevant with a diverse and changing stakeholder pool

spanning 3Ps (patients, payers, providers)• Optimization of big data, patient outcomes and positioning of range of evidence that can drive integrated value• Development of medical affairs models to engage with early R&D and drive differentiation through

“must have” components of TPP• Med Affairs ownership of Patient Centricity and evidence based application towards clinical &

commercial strategy• Shaping of corporate risk tolerance and compliance rather than be its recipient by focusing on evidence

based trusted partnershipsUsman Iqbal, MD, MPH, MBA, Senior Director, Medical Affairs & HEOR, Trevena, Inc

9:30 A Spotlight on Regulatory and Enforcement Trends Investigations involving life sciences companies for kickback violations, off-label promotion and inappropriate interactions with commercial teams continue to pose challenges for medical affairs professionals. During this session, hear about current areas of enforcement with a critical eye on medical affairs. • Off-label promotion• Open payments and anti-kickback violations• Challenges that arise in the medical affairs and commercial functions communicate• Recent settlements and the implications for medical affairs teams• Promotional issues and advisory boardsModerator:Jennifer Romanski, J.D., Vice President, Regulatory and Compliance Services, Porzio Life Sciences LLCPanelists: Dale Cooke, MA, President, PhillyCooke Consulting Timothy Grimes, Former, Health Care Compliance Officer, North American Pharmaceuticals, Johnson & JohnsonAngelique Lee-Rowley, US General Counsel & Compliance Officer, Greenwich Biosciences, Inc.

10:30 Networking and Refreshment Break

11:00 Measure and Elevate the Medical Affairs Value PropositionWith the evolution of our industry, medical affairs organizations are well positioned to provide scientific evidence that supports the appropriate use of products, services, and technologies. Historically, it has been a challenge to assess and quantify the true value of medical affairs organization in ensuring physicians are aware of new health technologies and patients have appropriate access. Development of robust metrics and methodologies for quantifying real-world “return on education” are critical to establishing true value. In this session, explore the importance of impact and performance metrics in addition to traditional measures of productivity and efficiency. Questions to be addressed:• What is the true value of a medical affairs organization?• What are the types of metrics that support such value?• How can a “story” be advanced to evidence the real world value of medical affairs? • What areas of compliance and best practices are relevant to the development of a medical

affairs value proposition?Robert Matheis, Executive Director, Head of Global Scientific Communications, Celgene


PANEL

Medical AffairsAdvancement ForumLeading Strategies to Advance Medical Science, Engage Compliantlywith KOLs and Ensure Success of Medical Affairs Teams

January 20-21, 2016 | Sonesta Hotel Philadelphia | Philadelphia, PA

DAY ONE | Monday, January 30, 2017



PANEL



DAY ONE | Monday, January 30, 2017 11:45 The Convergence of Pharmaceuticals and Technology – A New Treatment Paradigm• The changing environment in medication delivery• How can technology help improve patient care• What are the regulatory implications for medical affairs?Christian Eichhorn, Leader, Innovation Knowledge Operations, West Pharmaceutical Services

12:30 Networking Luncheon

Cultivate Compliant Interactions with Internal and External Stakeholders1:30 Engaging in Compliant Medical Affairs and Commercial Collaborations

• Establish guiding principles to differentiate scientific exchange and promotional activity• Develop internal SOPs to ensure compliant interactions and activities• Ensure independence and integrity of medical affairs and commercial functionsKaren Lowney, Executive Director/Global Ethics & Compliance, AstellasShontelle Dodson, Vice President, Medical Excellence/Medical Affairs Global, Astellas

2:15 Achieve Excellence in Your Product Launch Strategy Prescribers want to remain informed and pharmaceutical companies are looking for ways to raise awareness of the attributes of new products to distinguish them from competitive alternatives. With the ability to educate KOLs, a well-executed medical affairs launch strategy can help inform important stakeholders regarding the promise of an upcoming drug. During this session, learn best practices for the activities necessary for a successful launch, including how to:• Generate thought leader interest in the product• Provide internal education to brand teams and sales force• Make Certain all key thought leaders who drive treatment guidelines and protocols understand the drug• Ensure prescriber questions are answered and that they know exactly how to use the drugLance Hill, CEO, Within3

3:00 Networking Break

Take Your MSL Resources to the Next Level3:30 Establishing New KOL Relationships — Lessons Learned

This session dives into the importance of effective communication skills for both MSLs and medical affairs leadership. Explore key points, including:• Smart networking — Gain credibility and get exposed • The importance of pre-meeting preparation and the necessity for deep understanding of the clinical and

business needs of KOLs• How to add future value to engagements through continuous training and education• Onboard training expectations for new MSLs — How to help new MSL grow in the role. • The end goal — Becoming a trusted advisor and acting in a KOL and patient’s best interest Tiama Chaar, Ph.D., Oncology MSL, Sanofi Genzyme

4:15 Optimize Your MSL Utilization with Tailored Training and Education • How is training defined in your company? • What are the different types of training offered and how does that evolve with the progression of the MSL?

* on-boarding, continuing education, soft skills, etc.• What are some MSL developmental strategies utilized to optimize their impact within the field? • How to recruit and retain the right MSL• Best practices for training your MSLs to go global Moderator:Rashmi Morani, PharmD, MS, Senior Medical Science Liaison, Fresnius Medical CarePanelists:Scott McConnell, PharmD, Senior Director, Medical Affairs, Alkermes Kunal Ramani, PharmD, Medical Science Liaison, Actelion Josh Yoder, Medical Science Liaison, Sanofi Pasteur

5:15 Close of Day One

Networking, Wine and Cheese Receptionimmediately following the final session on day one



7:30 Continental Breakfast

8:00 Chairman’s Review of Day OneScott McConnell, PharmD, Senior Director, Medical Affairs, Alkermes

8:15 The Role of the MSL in Cultivating KOL Relationships and Managing the Risks of Collaborative ResearchIn this session we will discuss the compliance issues relating to the MSL’s role with a KOL’s relationship management. In further detail, we will discuss the following:• Balanced responsibilities in an Investigator Initiated Research• MSLs compliance considerations during the 5 phases of an IIR• Differences between IIR and outcomes research

Darren R. Jones, Partner, Polaris Management Partners

Streamline Key Activities for Improved Outcomes for Physicians and Patients

9:15 Establish Best Practices for Effective Advisory Boards (The Key Elements for Success)Pharmaceutical, Medical Device, and other healthcare spaces require the external voice to gain insights and exchange scientific and clinical knowledge. Advisory boards are a crucial tool to gain these insights required to achieve a deep understanding and interpretation of customers’ and patients’ needs and challenges. This allows us to better develop solutions that have relevant medical benefits. Advisory boards offer companies numerous opportunities to explore innovative approaches to new strategies in our rapidly changing healthcare system, create meaningful product portfolios that stretch the reach and access of care, engage in research from basic sciences to clinical solutions and business models, and to build advocacy and develop educational solutions for providers and patients. Examine the key fundamentals necessary to ensure that an advisory board delivers valuable insights that drive actionable results. • How do you develop a clear set of objectives for engaging with key thought leaders? • Overcome the perception of one directional meetings and design an interactive agenda• What is needed to translate meeting objectives into action steps?• What are the compliance pitfalls when planning an advisory board?• Implement effective monitoring and auditing processes• How do you measure the success of advisory boards?Kevin Appareti, Senior Director, Global Medical Science Liaison, Philips Healthcare

10:00 Networking and Refreshment Break

10:30 Optimize Your Medical Affairs Team’s Impact in a Start-up Organization During this session learn about the key considerations for small medical affairs teams, including how to:• Discover the unique challenges faced in small start-up biopharmaceutical companies• Understand your bandwidth and prioritize limited resources for optimal organizational outcomes• Expand your department’s impact by aligning with other functions to support corporate goalsRachel Leder Couchenour, PharmD, MBA, Senior Director, Medical Affairs, Mateon Therapeutics

11:15 Hot Topics Recap PanelThis session is intended to revisit the most popular topics shared throughout the course of the conference. Attendees have the chance to ask the speaking faculty questions that require more in-depth consideration.Panelists: Timothy Grimes, Former, Health Care Compliance Officer, North American Pharmaceuticals, Johnson & Johnson Josh Yoder, Medical Science Liaison, Sanofi Pasteur Angelique Lee-Rowley, US General Counsel & Compliance Officer, Greenwich Biosciences, Inc.

12:00 Close of Conference

DAY TWO | Tuesday, January 31, 2017

PANEL



CASE STUDY




WEBwww.cbinet.com/medicalaffairs

[email protected]

PHONE800-817-8601339-298-2100 outside the U.S.

LIVE CHATwww.cbinet.com/medicalaffairs

WAYS TO REGISTER NOW!CBI 70 Blanchard Road Burlington, MA 01803

A division ofUBM Americas

Medical Affairs Advancement Forums PC17320

VENUE: DoubleTree by Hilton Center City237 South Broad StreetPhiladelphia, PA 19107Phone Reservations: (800) 222-8733Hotel Direct Line: (215) 893-1600

ACCOMMODATIONS: To receive CBI’s special discounted hotel rate online or by phone, please go to:

• Online: www.cbinet.com/medicalaffairs• Phone reservations: (800) 222-8733 and mention CBI’s Medical Affairs

Book Now! The DoubleTree by Hilton Center City is accepting reservations on a space and rate availability basis. Rooms are limited, so please book early. All travel arrangements subject to availability.

PLEASE NOTE: All hotel reservations for this conference should be booked directly with the hotel. CBI does not use Housing Bureaus and none are authorized to call on our behalf.

REGISTRATION FEE: ADVANTAGE PRICING Standard Onsite Conference $1899 $2199 $2299

Register by December 23, 2016 and SAVE $300. Fee includes continental breakfast, lunch, wine and cheese reception, refreshments and conference documentation. Credit Card (Visa, MC, AMEX, Discover) or checks accepted. Please make checks (in U.S. funds drawn on a U.S. bank) payable to: CBI. (No personal checks accepted.) PLEASE NOTE: All advertised discounts are taken from the full, Standard Rate.

GROUP RATE: Looking to bring your team? Contact Information Services to learn about potential group savings. Call 800-817-8601 or email [email protected].

* Advantage pricing rates do apply when applicable. Offer may not be combined with any other special pricing promotions. Offer may be used at CBI co-located events.

SATISFACTION GUARANTEED: CBI stands behind the quality of its conferences. If you are not satisfied with the quality of the conference, a credit will be awarded towards a comparable CBI conference of your choice. Please contact 800-817-8601 for further information. Advanced preparation for CBI conferences is not required.

SUBSTITUTION AND CANCELLATION: Your registration may be transferred to a member of your organization up to 24 hours in advance of the conference. All cancellations received in writing on or before 14 days prior to the start date of the event will be refunded, less a $399 administrative charge. No refunds will be made after this date; however, the registration fee less the $399 administrative charge can be credited to another CBI conference if you register within 30 days from the date of this conference to an alternative CBI conference scheduled within the next six months. In case of conference cancellation, CBI’s liability is limited to refund of the conference registration fee only. Cancellation of a conference due to events beyond our control* are subject to a $399 administrative charge should you or a colleague be unable to attend the rescheduled date. CBI reserves the right to alter this program without prior notice. Please Note: Speakers and agenda are subject to change. In the event of a speaker cancellation, every effort to find a suitable replacement will be made. The opinions of the conference faculty do not necessarily reflect those of the companies they represent or CBI.

*Events beyond our control include: severe weather conditions, natural and man-made disasters and any other similar events.


R E G I S T E R BY D E C E M B E R 2 3 , 2 0 1 6 A N D S AV E $ 3 0 0 !

Medical AffairsAdvancement ForumMSL Best Practices • KOL Engagement Compliant Medical Communications

January 30-31, 2017 | DoubleTree by Hilton Center City | Philadelphia, PA

ANY QUESTIONS OR TO REGISTERCONTACT: John Kuchinski

phone 339-298-2112email [email protected]









https://twitter.com/CBI_Conferences

https://www.linkedin.com/company/the-center-for-business-intelligence

https://www.facebook.com/CBIConferences/


doubletree by hilton center city philadelphia, pa medical...

Documents